Brian M. Silver

Brian M. Silver (finance chief) discloses dealings in TScan Therapeutics, Inc. to SEC (Form 4). We count 6 filings; the first trade dates from 20 July 2021 and the latest from 28 December 2022.

On the market, this insider has only ever bought: 6 purchases, €137k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: 3 purchases and no sales on the market.

In size, the median ticket on the buying side is €20k. On 3 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 29 December 2022 with an open-market purchase (€4,631) in TScan Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.